Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn L Silver

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry|July 7, 2016
A Gestalt approach to Gram-negative entryLynn L Silver
Idrugs : the Investigational Drugs Journal|July 27, 2005
A retrospective on the failures and successes of antibacterial drug discoveryLynn L Silver
Idrugs : the Investigational Drugs Journal|June 6, 2006
Antibacterial drug discovery and development--SRI's 11th Annual Summit. Antibacterial trends and current researchLynn L Silver
Expert Opinion on Drug Discovery|March 15, 2013
Are natural products still the best source for antibacterial discovery? The bacterial entry factorLynn L Silver
Future Microbiology|October 31, 2015
Natural products as a source of drug leads to overcome drug resistanceLynn L Silver
Biochemical Pharmacology|November 18, 2005
Does the cell wall of bacteria remain a viable source of targets for novel antibiotics?Lynn L Silver
Cold Spring Harbor Perspectives in Medicine|September 8, 2016
Appropriate Targets for Antibacterial DrugsLynn L Silver
Cold Spring Harbor Perspectives in Medicine|January 8, 2017
Fosfomycin: Mechanism and ResistanceLynn L Silver
Nature Biotechnology|November 8, 2014
Antibacterials for any targetLynn L Silver
Clinical Microbiology Reviews|January 15, 2011
Challenges of antibacterial discoveryLynn L Silver
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry|July 7, 2016
A Gestalt approach to Gram-negative entryLynn L Silver
Idrugs : the Investigational Drugs Journal|July 27, 2005
A retrospective on the failures and successes of antibacterial drug discoveryLynn L Silver
Idrugs : the Investigational Drugs Journal|June 6, 2006
Antibacterial drug discovery and development--SRI's 11th Annual Summit. Antibacterial trends and current researchLynn L Silver
Expert Opinion on Drug Discovery|March 15, 2013
Are natural products still the best source for antibacterial discovery? The bacterial entry factorLynn L Silver
Future Microbiology|October 31, 2015
Natural products as a source of drug leads to overcome drug resistanceLynn L Silver
Biochemical Pharmacology|November 18, 2005
Does the cell wall of bacteria remain a viable source of targets for novel antibiotics?Lynn L Silver
Cold Spring Harbor Perspectives in Medicine|September 8, 2016
Appropriate Targets for Antibacterial DrugsLynn L Silver
Cold Spring Harbor Perspectives in Medicine|January 8, 2017
Fosfomycin: Mechanism and ResistanceLynn L Silver
Nature Biotechnology|November 8, 2014
Antibacterials for any targetLynn L Silver
Clinical Microbiology Reviews|January 15, 2011
Challenges of antibacterial discoveryLynn L Silver
Pageof 4